Futibatinib is a type of medicine aimed at FGFR2 fusions in bile duct cancer. You can find it as 4 mg tablets. doctors usually suggest taking 20 mg of it just once a day.
The tablets usually come in boxes with 28 in each. How Futibatinib works is by stopping FGFR signaling — super important for treating cancers with FGFR2 fusion changes.